Commentary
Video
Dr Bertossi on the Prognostic Role of TP53 Mutations in CLL
Author(s):
Consuelo Bertossi, MD, discusses the role of TP53 mutations and their prognostic significance in chronic lymphocytic leukemia.
Consuelo Bertossi, MD, assistant doctor, Division of CLL, Department of Internal Medicine III, Universitätsklinikum Ulm, discusses research further elucidating the role of TP53 mutations and their prognostic significance in chronic lymphocytic leukemia (CLL), as presented at the 2024 EHA Hybrid Congress.
Related Videos
Related Content
